← Back to headlines
Argenx to Acquire Forte Biosciences for $2.2 Billion
Argenx has signed an agreement to acquire Forte Biosciences in a deal valued at $2.2 billion.
28 Jul, 09:35 — 28 Jul, 09:35
Sources
Showing 1 of 1 sources
Related Stories
Climate Catastrophes in Europe Cost Billions, Burdening Citizens
25m ago
Former Google CEO Eric Schmidt Selling Superyacht for €149 Million
26m ago
Berkshire Hathaway's Significant Investment in Alphabet Stock
33m ago
Fabrinet Shares Decline Despite Earnings Beat Due to Margin and Cash Flow Concerns
49m ago